What's New
Accuretic®(quinapril/hydrochlorothiazide) withdrawalJuly 5, 2022
Accuretic® (quinapril and hydrochlorothiazide 10/12.5 and 20/12.5 mg tablets) is being withdrawn and supplies will run out from August 2022. Patients will need to be switched to an alternative. Either: Switch to a separate ACE inhibitor and thiazide diuretic: Our recommendation is to replace this with perindopril and bendroflumethiazide. Quinapril tablets remain available and can […]
Nirmatrelvir with ritonavir (Paxlovid®) for patients with COVID-19April 6, 2022
Nirmatrelvir with ritonavir (Paxlovid®) is now available for patients with COVID-19 who are at high risk of severe disease. This bulletin discusses drug interactions that can occur with ritonavir, some of which may be potentially life-threatening. Further information on use of Paxlovid® can be found at: Ministry of Health – Therapeutics for the treatment of […]
Bulletin: Complementary and Alternative Products – QualityNovember 17, 2021
The use of complementary and alternative products (CAPs) such as herbals, dietary supplements, probiotics and homeopathic products is very common. However, most products sold in Aotearoa NZ are unregulated. This bulletin describes the problems reported regarding the quality of CAPs. CAP Quality
WORLD ANTIMICROBIAL AWARENESS WEEK 18 – 24 November 2021: Spread Awareness, Stop ResistanceNovember 17, 2021
Antimicrobial resistance is a growing problem in Aotearoa New Zealand and globally it is a crisis. This year the focus of the Awareness Week is on improving the understanding for both health professionals and patients of penicillin allergy and the harms associated with incorrect allergy labelling. CDHB Antimicrobial Stewardship Committee has produced the following bulletins […]